Public market insider buying at Diagnos (ADK)

Public market insider buying at Diagnos (V:ADK)

Updated Monday Oct 19, 2020 03:59 AM EDT
Tristram Coffin, a 10% Holder, acquired 233,000 Common Shares on a direct ownership basis at prices ranging from $0.550 to $0.670 between October 14th and 15th, 2020. This represents a $139,395 investment into the company's shares and an account share holdings change of 17.0%.

Diagnos is in the Software Sub Industry Group under the Technology Sector.

DIAGNOS Inc. provides data mining and interpretation consulting services, and designs data analytics software products. The Company operates through two segments: Healthcare and Natural resources. Its Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis (CARA), a software tool, which assists health specialists in the detection of diabetic retinopathy. CARA is a hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. Its Natural resources segment offers data mining consulting services through Computer Aided Resource Detection System (CARDS), a software tool used to assist exploration companies in identifying mining deposits. In addition, it offers project management services. The Company operates in Canada, the United Arab Emirates, India, Mexico, Switzerland, the United States, Poland and Colombia. Diagnos Inc. (ADK) has a high amount of executive buying compared to its micro-cap peers in the market over the past three months. According to recent regulatory filings, one insider has invested a total amount of $139,395.

Headlines: Oct 19, 2020

ADK Insider Holdings Chart

Issuer details as of Oct 19, 2020 3:59 ET

Latest Price
0.59
1 Day Change
1.72%
52 Week High
0.67
52 Week Low
0.1
QMV ($Mils)
36,205,942
Issuer website: https://www.diagnos.com/


Top